Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Buchegger

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Revue Medicale Suisse|August 11, 2015
[CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): a new facility]David Viertl, Franz Buchegger, John O Prior, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
131I-rituximab: relationship between immunoreactivity and specific activityAndreas O Schaffland, Franz Buchegger, Marek Kosinski, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 14, 2009
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor modelPol-Edern Le Renard, Franz Buchegger, Alke Petri-Fink, et al.
BJU International|April 13, 2007
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomyHansjörg Vees, Franz Buchegger, Susanne Albrecht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remissionFranz Buchegger, Cristian Antonescu, Claudine Helg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomasYves M Dupertuis, Wei-Hong Xiao, Nicolas De Tribolet, et al.
Molecular Imaging and Biology|September 3, 2010
[¹¹C]acetate PET/CT visualizes skeletal muscle exercise participation, impaired function, and recovery after hip arthroplasty; first resultsFranz Buchegger, Osman Ratib, Jean-Pierre Willi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridinePhilippe A Coucke, E Cottin, David Azria, et al.
Radiation Research|March 22, 2017
TAT-RasGAP<sub>317-326</sub> Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell DeathPelagia Tsoutsou, Alessandro Annibaldi, David Viertl, et al.
Radiation Oncology (London, England)|August 10, 2012
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CTHansjörg Vees, Charles Steiner, Giovanna Dipasquale, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Revue Medicale Suisse|August 11, 2015
[CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): a new facility]David Viertl, Franz Buchegger, John O Prior, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
131I-rituximab: relationship between immunoreactivity and specific activityAndreas O Schaffland, Franz Buchegger, Marek Kosinski, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 14, 2009
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor modelPol-Edern Le Renard, Franz Buchegger, Alke Petri-Fink, et al.
BJU International|April 13, 2007
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomyHansjörg Vees, Franz Buchegger, Susanne Albrecht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remissionFranz Buchegger, Cristian Antonescu, Claudine Helg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2002
Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomasYves M Dupertuis, Wei-Hong Xiao, Nicolas De Tribolet, et al.
Molecular Imaging and Biology|September 3, 2010
[¹¹C]acetate PET/CT visualizes skeletal muscle exercise participation, impaired function, and recovery after hip arthroplasty; first resultsFranz Buchegger, Osman Ratib, Jean-Pierre Willi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridinePhilippe A Coucke, E Cottin, David Azria, et al.
Radiation Research|March 22, 2017
TAT-RasGAP<sub>317-326</sub> Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell DeathPelagia Tsoutsou, Alessandro Annibaldi, David Viertl, et al.
Radiation Oncology (London, England)|August 10, 2012
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CTHansjörg Vees, Charles Steiner, Giovanna Dipasquale, et al.
Pageof 5